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Abstract:  We present the rare case of a 47-year-old patient, suffering from cheilitis granulomatosa and lupus ery-
thematosus discoid: this association is really exceptional because only once reported in English literature. In addi-
tion, the treatment of cheilitis granulomatosa is a challenge for the dermatologist: the gold standard, represented 
by steroids, is in fact designed as a short-time option. Our report confi rms the good effi cacy of methotrexate as a 
steroid-sparing agent.
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 INTRODUCTION
Miescher cheilitis is a chronic condition of un-
known aetiology, clinically characterized by recurrent 
or persistent swelling of one or both lips and histo-
logically by non necrotizing granulomas. Its therapy is 
usually a challenge for dermatologists: the fi rst choice 
is based on steroids, but, unfortunately, the result is 
temporary and additional therapy is necessary.
We present a rare case of cheilitis granulomato-
sa associated with lupus erythematosus discoid, treat-
ed with methotrexate with complete resolution.
CASE REPORT
A 47-year-old white man attended our Depart-
ment complaining about a persistent painless swelling 
of the upper lip, present for fi ve years. The patient re-
ferred that at the onset this enlargement was episodic 
but recurrent. Family and personal history was com-
pletely negative.
Physical examination revealed a homogeneous 
swelling of the upper lip, without clinical signs of 
erythema or edema of tongue and pharynx. Further-
more, in the same area, there were some erythematous 
lesions, characterized also by closely adherent scales, 
that had appeared only one year before (Figure 1). 
Other smaller erythematous lesions were present on 
the neck, while on the shoulders there were some ach-
romic and scarring lesions. Two skin biopsies for his-
topathological examination were performed.
Histopathological examination of the swelling 
showed upper dermis vasodilation with perivascular 
infi ltrate of lymphocytes, while in the reticular der-
mis non-necrotizing granulomas constituted by epi-
thelioid cells and Langhans’ type cells were observed 
(Figure 2). In the other histology  the epidermis was 
atrophic and characterized by hyperkeratosis and vac-
uolar degeneration of the basal cells (Figure 3). The 
upper dermis showed a perivascular and periadnexal 
infi ltrate of lymphocytes, while a large amount of mu-
cin was seen among collagen bundles.
Laboratory exams, including immunological 
markers, were totally negative or within normal range.
Our diagnosis was cheilitis granulomatosa, as-
sociated with lupus erythematosus discoid.
We treated the patient with hydroxychloroquine 
and methylprednisolone with prompt resolution of lu-
pus, but during reduction of the steroid there was a 
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new episode of swelling. Therefore, we added meth-
otrexate 15 mg per week for six months, then reduced 
to 10 mg per week for two years. No relapses were 
reported by the patient during a three-year follow-up.
DISCUSSION
Miescher cheilitis is a condition of unknown 
aetiology characterized by recurrent or persistent 
swelling of one or both lips. It was described by Gui-
do Miescher in 1945, after Melkersson and Rosenthal 
recognized the syndrome that nowadays holds their 
name in 1933.1 This syndrome, in fact, is composed of 
three symptoms: cheilitis granulomatosa, paralysis 
of facial nerve and fi ssured tongue. Miescher, several 
years later, noticed that in many cases cheilitis was not 
followed by the other two conditions and therefore 
considered it as a unique manifestation. Nevertheless, 
it should be stressed that the simultaneous presence of 
two or three elements of the syndrome is very uncom-
mon and therefore Miescher cheilitis may be consid-
ered sometimes as a temporaneous diagnosis. 2
Cheilitis granulomatosa is a rare infl ammato-
ry granulomatosus disease, characterized by non ca-
seating granulomas, vasodilation and perivascular 
lymphocytic infi ltrate. In the histological differential 
diagnosis, Crohn disease, sarcoidosis and infectious 
mycobacterial conditions must be included. Further-
more, some authors consider cheilitis granulomatosa 
as the extraintestinal form of Crohn disease, preced-
ing or following the diagnosis of intestinal disease of 
several years and suggesting to rule out infl ammatory 
bowel disease in case the patient complains of gastro-
intestinal symptoms. 3,4 
The fi rst manifestation of cheilitis granuloma-
tosa is a painless swelling involving one or both lips: 
this episode may resolve in a few hours and a relapse 
may occur in the following days. The episodes may in-
crease in duration until they become persistent. Some-
times, the swelling is accompanied by headache, mild 
fever and other non specifi c symptoms.
To confi rm the diagnosis, a biopsy for histo-
pathological examination is necessary. In early stages, 
only perivascular infi ltrate and edema of the upper 
dermis are found, while in chronic stages, non necro-
tizing granulomas composed of epithelioid cells are 
present in the reticular dermis.
As the causative mechanisms are unclear, prob-
ably a polyetiological interplay of environmental ex-
posures and genetic predisposition, the therapy is 
actually a challenge to dermatologists: in English lit-
erature, there are nowadays only a few case reports or 
small case series, with no comparative trials. The gold-
en standard is usually based on steroids: intralesional 
triamcinolone has been suggested by many authors as 
the fi rst choice therapy, followed by topical clobetasol 
FIGURE 1: Persistent swelling of the upper lip, associated 
with erythematous-desquamative lesions
FIGURE 3: Atrophic epidermis with hyperkeratosis and va-
cuolization of the basal layer. In the dermis, perivascular in-
fi ltrate and deposit of mucin among collagen bundles [H-E 
10x]
FIGURE 2: Non necrotizing granulomas in the reticular 
dermis [H-E 20x]
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and systemic steroids. 5 Nevertheless the result is tem-
porary and this kind of therapy must be stopped af-
ter a while for the well known side effects; therefore, 
additional therapy is necessary. Other options are 
clofazimine, antibiotics such as tetracycline and met-
ronidazole, immunomodulators, such as infl iximab, 
thalidomide, dapsone and methotrexate. 6
Our case is really exceptional because of the 
association, very rare in English literature, of cheilitis 
granulomatosa and lupus erythematosus discoid: to 
our knowledge, it has been reported only once. 7,8 This 
association could help to clarify the pathogenesis of 
cheilitis granulomatosa as an immunological disease 
but further studies are required.
The second reason for interest is the therapy we 
chose. Initially we treated our patient with systemic 
steroid, as suggested by most reports, but at the dose 
reduction a relapse was recorded. A new systemic ther-
apy was administered that could also be used with lu-
pus erythematosus discoid: hydroxychloroquine and 
methotrexate, with a ready benefi t. Our case, there-
fore, represents another evidence of the effectiveness 
of methotrexate as a steroid-sparing drug in cheilitis 
granulomatosa. 9,10 ❑
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